Compare RLMD & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLMD | TWI |
|---|---|---|
| Founded | 2004 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.9M | 453.1M |
| IPO Year | 2012 | 1997 |
| Metric | RLMD | TWI |
|---|---|---|
| Price | $4.07 | $6.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $12.40 | $12.00 |
| AVG Volume (30 Days) | ★ 1.1M | 525.2K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | $3.69 |
| Revenue Next Year | N/A | $4.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $1.47 | $6.37 |
| 52 Week High | $8.00 | $11.70 |
| Indicator | RLMD | TWI |
|---|---|---|
| Relative Strength Index (RSI) | 35.21 | 44.28 |
| Support Level | $3.99 | $6.40 |
| Resistance Level | $4.51 | $8.17 |
| Average True Range (ATR) | 0.21 | 0.35 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 12.31 | 2.92 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. It designs and manufactures products for OEMs and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. The company operates through three segments, namely Agricultural, Earthmoving/Construction, and Consumer. It derives the majority of revenue from the Agricultural segment which manufactures various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment. Geographically, the company generates the maximum revenue from North America, followed by Europe / CIS, Latin America, and Asia and other regions.